Bloodletter, the debut game from Aldamami Games, has been in Early Access since late March 2026. We spoke to Katharina 'Mikey' Müller to find out how satisfied the team is with the launch, how the game is faring in the competitive deck-building genre, and what their plans are for the future.
The Berlin-based game studio Aldamami Games is releasing the first major content update for its game Bloodletter today. This update features a new entity to cleanse across three different difficulty levels, 21 new cards and two new transmuters. The game has been in Early Access since the end of March, so we caught up with Katharina 'Mikey' Müller to discuss how Aldamami Games' debut title has fared so far, and why it hasn't really taken off yet. She also discussed how to generate more interest in the game given the crowded nature of the deck-builder genre on Steam, and what the future holds for the young team during Early Access and beyond.
GamesMarket: How satisfied are you with the Early Access phase so far?
Katharina "Mikey" Müller: "We are quite happy with the way our Early Access phase is going and it's been really exciting so far. Since we have never done an Early Access before we were unsure of what to expect but it's been really motivating to see how much time players are already putting into the game and how they're hungry for more content. We are really grateful for all the feedback we've gotten so far, no matter how harsh. Early Access has been a great opportunity to really hear from the people and get a grasp of player expectations when they've actually paid for a game and aren’t just playing a free demo they kind of like."
"Overall we hope to be able to attract more players to Bloodletter with continued updates and community involvement but either way we are already really happy and thankful for all our players so far."
Bloodletter is a medieval deck-building game in which players use cards to heal bizarre villagers. Players must protect the villagers' bodies and minds from the torment of mysterious entities by customising their unique decks and enhancing dubious healing methods.
Bloodletter © Aldamami Games
GamesMarket: Were you hoping for more interest from players, particularly in terms of sales? In your opinion, why hasn't Bloodletter really taken off yet?
